For gene therapy approaches to succeed, improved vector transfected E5 helper cells. This system allows for efficient systems are needed that combine a large carrying capacity packaging of high-titer vector since the E5 cells are first with high transduction efficiency in vivo. Towards this goal, selected for the presence of the pHE vector before helper we have developed a novel herpes simplex virus (HSV) virus infection. The infectious pHE vector has efficient amplicon vector, pHE, which contains an HSV-1 replication transgene expression in a variety of human cell lines in origin (ori S) and packaging sequence that permit vector repvitro. Stereotactic injection of pHE vector supernatant into lication and packaging into HSV-1 capsids. The vector also the rat brain resulted in high, localized reporter gene contains the Epstein-Barr virus (EBV) unique latent repliexpression. Finally, the pHE vector could carry a stable 21 cation origin (ori P) sequence and a modified EBNA-1 gene kb DNA payload into HSV virions. This pHE vector system to allow the vector to be maintained as an episome in should have a broad range of gene transfer applications.
cells. Disabled viral vectors have shown promising p.f.u./ml), but often have significant host cell toxicity results both in vitro and in vivo [1] [2] [3] [4] [5] and several viral vectors which is predominantly seen in dividing cells in culture are now in widespread use in phase I and II clinical trials. and depends on which viral genes have been Viral vectors currently in trials have various limitations deleted. 8, 14, 15 These vectors are the first of two types of such as an inability to infect post-mitotic cells, low insert HSV-based vectors under development. carrying capacity, inefficient transfer or immune destruc-
The second broad category of HSV-based vectors is tion. Continued improvements in these standard vector amplicons. 16 Plasmids containing a HSV-1 lytic repliclasses are occurring, such as the recently described Lenti cation origin (ori S) and the 'a' HSV-1 terminal packaging retroviral vector that can infect post-mitotic cells. 6 None signal sequence, can be amplified and packaged into the less, these limitations have led investigators to infectious HSV-1 virions in the presence of transacting explore alternative viral vector systems such as those helper virus. [16] [17] [18] [19] This plasmid-based vector permits facile based on the herpes simplex virus.
cloning and carries genomic information between prokarModified herpes simplex virus type-1 (HSV-1) gene yotic cells and eukaryotic cells as a shuttle vector. The transfer vectors are capable of infecting a variety of mamamplicon systems retain the merits of wide tropism of malian cells and can persist in a latent state in neural standard HSV-1 vectors, but the viral stocks tend to have cells. 7, 8 HSV-1 is a large, enveloped, double-stranded lower titers. The titers of amplicon vectors can be DNA virus that is composed of approximately 152 kb increased by serial passaging of the amplicon viral stocks encoding 81 genes. 9 The HSV-1 genome contains three on the complementing cell line. 16 However, this process replication origins and encodes several proteins that also increases the probability of generating wild-type modulate viral and cellular gene expression in a temporal virus within the amplicon stocks. 8 In addition, the ratio cascade from three different transcription units, of amplicon to helper virus changes with each passage. immediate-early (IE), early or late. 10, 11 Helper viruses This ratio must be monitored at each round of production have been generated by deleting IE genes essential for to identify optimal ratios and titers of amplicon. 25 EBV has been demonstrated to contain a unique latent replication origin (ori P) which directs viral cells and in target cells. Hygromycin resistant gene (hyg + ) was driven by HSV-1 thymidine kinase (HSVtk) proself-replication and maintenance in cells without entering the lytic cycle. 26, 27 The EBV nuclear antigen 1 (EBNA-1) moter and terminated by HSVtk poly A signal. The pHE700-lac was generated by inserting a lacZ gene into encodes a DNA binding transactivator for ori P. [26] [27] [28] [29] Investigators previously have demonstrated that plasmid the multiple cloning site in pHE700 driven by the human cytomegalovirus (CMV) immediate-early gene enhancervectors containing the EBV ori P that also expressed the EBNA-1 gene were more effective eukaryotic expression promoter. The pHE700B-GFP contains both a 16.8 kb BamHI DNA fragment of phage and a 4.2 kb DNA fragvectors. 26 Various groups have used such EBNA-1-based vectors for expression in human tumors with therapeutic ment containing a humanized, red shifted green fluorescent protein (GFP).
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intent. 30 The combination of the HSV amplicon with the EBV sequences improves the ease of use of the HSV amplicon system. The new system overcomes the inconEpisomal maintenance and viral packaging venience of serial passaging to produce high-titer
The maintenance of the pHE vector as an episome was amplicon vector. Since helper cells can be transfected and demonstrated by transfection of pHE700-lac into E5 cells selected for the pHE plasmid, a single round of helper and selection with hygromycin ( Figure 2 ). The initial virus infection produces relatively higher titers (up to transfection efficiency was generally Ͻ10% as detected 2 × 10 6 b.f.u./ml). Our replication incompetent pHE vecby 5-bromo-4-chloro-3-indolyl-␤-d-galactopyranoside (Xtors maintained wide tropism for delivering transgene(s) gal) staining 24 h after transfection ( Figure 2a ). By 16 into both dividing and quiescent cells with high days after hygromycin selection, resistant colonies efficiency both in vitro and in vivo. Furthermore, our developed and most cells expressed ␤-galactosidase improved vector could carry a stable 21 kb DNA insert.
( Figure 2d ). Selected E5 cells containing pHE700-lac plasmid were then infected with d120 helper virus. The resulting supernatants contain both the pHE700-lac vec-
Results
tor and helper virus. The multiplicity of infection (MOI) of the helper virus added was between 0.01 and 0.1 to The pHE vector The pHE700, herpes amplicon vector is illustrated in Fig- induce viral vector production within 24-36 h. The titer of d120 helper virus was defined as plaque forming units ure 1. The vector contains the HSV-1 'a' sequence for the package/cleavage signal and an ori S replication origin (p.f.u.) and the titer of pHE700-lac was defined as blue cell forming units (b.f.u.). The average titer obtained was to permit plasmid replication and packaging in the presence of helper virus (d120) in E5 helper cells. The vector 2 × 10 6 b.f.u./ml with a ratio of pHE700-lac vector (b.f.u.) to d120 helper virus (p.f.u.) that ranged from 1:1 to 1:20. also contains an ori P and a ⌬EBNA-1 gene which is con- Figure 1 After centrifugation by sucrose gradient ultra-centrifugused to infect VA13 and T98G cells which delivered about 30 MOI of d120 helper virus when 3 MOI of ation, we obtained a pHE700-lac titer of 1 × 10 8 b.f.u./ml. Without hygromycin selection, however, the titers of pHE700-lac amplicon vector was applied. The cytotoxicity was evident 2 days after transduction. The transduced pHE700-lac vector can only be generated at the range of 10 4 to 10 5 b.f.u./ml from the transfected E5 cells cells demonstrated altered morphology secondary to cytotoxicity ( Figure 3e ) and the number of the stained depending on transfection efficiency.
cells was greatly reduced due to cell loss ( Figure 3f ). To eliminate the possibility that the lacZ activity observed Transduction and expression in vitro of the pHE700-lac vector was from 'pseudo-transduction' secondary to ␤-galactosidase protein contamination of the packaged vector, a The pHE700-lac containing supernatants were used to transduce human target cells in vitro. All in vitro experitime course of lacZ gene expression was tested. VA13 cells were transduced by pHE700-lac vector, d120 helper ments were carried out by employing amplicon vector stocks with a 1:1 ratio of pHE700-lac vector to d120 virus or mock-transduced with culture medium. The cells were lysed 2 or 24 h later and the ␤-galactosidase activity helper virus. The ␤-galactosidase gene expression was evaluated after infection with pHE700-lac vector (3) (4) (5) (6) (7) (8) (9) (10) was determined by O-nitrophenyl-␤-d-galactopyranoside (ONPG) assay. 32 The lacZ gene expression was only MOI b.f.u.) in various cultured human cells including VA13 human fibroblasts (Figure 3a ), T98G human glionoticed 24 h after the pHE700-lac vector transduction. The 2 h time-point demonstrated a similar ONPG reading blastoma cells (Figure 3b ), IGROV human ovarian carcinoma cells (Figure 3c ), and XP2OS xeroderma pigas compared with the VA 13 cells that were not transduced or transduced with d120 helper virus ( Figure 4 ). mentosum fibroblasts (Figure 3d ). All cells were fixed and stained with X-gal 2 days after infection. When using Therefore, the ␤-galactosidase activity visible at the 24 h time-point reflects the transduced gene expression from a lower MOI (1 MOI of b.f.u.), the lacZ gene expression was detected for approximately 2 weeks, with a peak the pHE700-lac vector. expression occurring 48-72 h after transduction. To dem-
The pHE vector insert capacity onstrate the cytotoxicity caused by helper virus, a low A 16.8 kb fragment obtained by BamHI restriction bacratio of pHE700-lac vector to d120 helper virus (1:10) was teria phage genomic DNA and a 4.2 kb plasmid 31 that
Figure 3 In vitro expression of the pHE700-lac vector. Photographs of various human cell lines are shown 2 days after infection with pHE700-lac virus stock. The cells transduced with 3 MOI (a, e and f) or 10 MOI (b-d) of pHE700-lac vector at the ratio 1:1 (a-d) or 1:10 (e and f) of the vector to helper virus. (a) VA13 normal fibroblasts, (b) T98G human glioblastoma cells, (c) IGROV human ovarian carcinoma cells, and (d) XP2OS xeroderma pigmentosum fibroblasts, (e) VA13, (f) T98G.
carries a humanized green fluorescent protein (GFP) gene episomal vector DNA and the helper viral DNA were isolated from either the transfected E5 cells or the packaged were inserted into the pHE700 vector. The resulting plasmid, pHE700B-GFP, was transfected into E5 cells and virus stocks. The isolated DNA was digested with BamHI or XhoI and underwent pulsed field gel electrophoresis. packaged by infection with Cgal⌬3 helper virus. The packaged pHE700B-GFP vector was then used to infect
The membrane was probed using a 32 P-labeled 16.8 kb BamHI fragment. An autoradiogram of this Southern VA13 cells and green fluorescence was observed from the transduced cells (data not shown). To demonstrate analysis is shown in Figure 5a . Transfected pHE700B-GFP vector DNA is present as an episome in DNA further the stability of the amplicon packaged DNA, the maximum distance of 1 mm surrounding the site. No secondary sites of X-gal staining were detected. The majority of cells expressing ␤-galactosidase were neurons defined by the presence of typical neuronal processes in the caudate (Figure 6a ) or by their location in the dentate gyrus and morphology characteristic of granular cells ( Figure  6b and c). LacZ gene expression was observed for at least 2 weeks after injection with greatly decreased ␤-galactosidase activity (Figure 6d ). Control rats injected with media alone showed essentially no X-gal-positive staining in these areas at 2 or 14 days after injection.
Discussion
Our results demonstrate the utility of a novel herpesvirus-based amplicon vector system, pHE, for generating high-titer amplicon stocks, efficient transgene transfer into mammalian cells in vitro and in vivo and an improved carrying capacity. The vector is efficiently packaged in the presence of IE3 defective helper virus because the vector contains the HSV-1 package/cleavage elements and replication origin. Our vector also contains the ⌬EBNA-1 gene and the EBV ori P to permit the vector to be maintained as an episome within the nucleus and to replicate with cell division. Our vector, in comparison with the other recently reported system, 25 is relatively smaller in size and contains a modified EBNA-1 to enhance plasmid stability while causing less toxicity than (Figure 5a, lane 3) . Figure 5a , lanes 4-6, are corresponding restriction analyses of DNA obtained from packaged 1 × 10 8 b.f.u./ml after centrifugation). Previous reports in amplicon systems, found that three or four repeat cycles pHE700B-GFP vector. Lane 4 shows the unrestricted full-length vector with multiple copies of pHE700B-GFP of helper virus superinfection were needed to achieve high vector titers. 16, 18, 23 The hygromycin selection in our vector genome (152 kb) and lanes 5 and 6 represent XhoI and BamHI restriction digest, respectively. A schematic system results in almost all of the E5 cells containing pHE plasmid (Figure 2d ) before the addition of d120 helper diagram of the pHE700B-GFP vector is shown in Figure  5b . These results demonstrate that the pHE700 vector has virus and results in a viral titer of 2 × 10 6 b.f.u./ml. In comparison, without hygromycin selection, the transthe capability to carry large DNA inserts and transfer functional gene (GFP, in this case) into host cells through fected E5 cells only generated titers of 10 4 to 10 5 b.f.u./ml after infection with helper virus. However, the ratio of infectious packaged vector.
amplicon vector to helper virus in both systems varied widely. We obtained ratios from 1:1 to 1:20 of amplicon In vivo expression of the pHE700-lac vector in the rat central nervous system to helper virus. Helper virus may replicate and package preferentially compared with amplicon vectors. The titer The efficiency of pHE700-lac vector for gene delivery into the central nervous system (CNS) was evaluated next.
of helper virus used to package amplicon vectors was a critical factor, but we have not yet determined how to The caudate nucleus or hippocampus of rats were injected with pHE700-lac viral vector supernatant (2 × 10 5 produce lower ratios of helper virus consistently. Using a 0.1 to 0.01 multiplicity of helper virus generally gave b.f.u.) stereotactically. High ␤-galactosidase expression was found around the injection site within the caudate favorable results. The replication defective HSV helper virus (d120) in nucleus and the dentate gyrus (hippocampus) as determined by X-gal staining 48 h after injection (Figure 6) . amplicon viral stocks causes substantial cytotoxicity to infected cells. 8, 14, 15 This cytotoxicity correlates with a low Gene expression in these brain areas was detected between 2 and 14 days after injection and was most ratio of amplicon vector to helper virus (Figure 3e and f). 25 However, injection into rat brain with a total of prominent between 2 and 7 days. Intense X-gal staining was observed in cells at the injection site and to a 2 × 10 5 b.f.u. pHE700-lac vector demonstrated excellent in a b vivo transduction and the transgene expression can last 1 virions ( Figure 5 ). The pHE700B-GFP vector successfully transduced VA13 human fibroblasts and expressed for at least 2 weeks (Figure 6 ). The higher ratio of amplicon to helper virus is a critical factor to be con-GFP activity as noted by green fluorescence. Southern analysis of the harvested pHE700B-GFP viral DNA sidered when using this system for gene delivery. Our pHE vector provides the ability to generate higher vector demonstrated a stable insert carried by the vector and packaged into HSV virions. One 16.8 kb BamHI band was to helper virus ratio stocks compared with other amplicon systems. Developing even more favorable demonstrated after restriction of DNA from pHE700B-GFP virions ( Figure 5 ). This is the first demonstration that ratios of amplicon and helper virus, generating less cytotoxic helper viruses by deletion of more IE genes 8 or amplicon vector could carry larger inserts without significant DNA loss compared with previously reported using the newly developed helper virus-free packaging systems should further reduce or eliminate the cytotoxic-HSV-1 based amplicon vectors. 17 Southern analyses on pHE700B-GFP vector stocks after serial passage showed ity produced by amplicon vectors. 33 Another major advantage of this novel amplicon systhat the insert was stable for at least six passages (data not shown). One possibility is that our vector containing tem is the large DNA insert capacity compared with other viral vector systems. The pHE700B-GFP contains the ori P and ⌬EBNA-1 elements may aid not only plasmid maintenance but also plasmid genome stability after both a 16.8 kb phage DNA fragment and a 4.2 kb plasmid fragment containing GFP sequence. This vector was transfection or during packaging. The ability to carry larger DNA inserts offers a potential advantage over size transfected in E5 cells and effectively packaged into HSV- amplicon can persist at least for 2-3 months after in vivo transduction, as demonstrated in a recent study. 35 Longalthough the upper limit of such an adenoviral vector will be about 30 kb, while the theoretical capacity of the term transgene expression may be improved by replacing the CMV promoter with the transcriptional control mechpHE700 amplicon vector may be about 140 kb. If realized, this would provide the opportunity for transfer of a gene anisms of the natural viral latency active promoter or HSV latency associated promoter. 8 The vector might also in the genomic DNA form to human cells.
Figure 5 Autoradiogram of pHE700-B-GFP vector and schematic. (a) Lanes 1-3 show analyses of DNA isolated from pHE700-B-GFP plasmidtransfected E5 cells. Lane 1 was nonrestricted and represents episomal plasmid. Lane 2 was treated with XhoI that linearized the plasmid. Lane 3 was restriction digested with BamHI to drop out the 16.8 kb phage insert. Lanes 4-6 show analyses of DNA isolated from packaged pHE700-B-GFP vector supernatant. Lane 4 was nonrestricted and represents the full-length 152 kb vector genome. Lanes 5 and 6 show corresponding restriction digest analyses of the packaged pHE700B-GFP DNA after XhoI and BamHI restriction digest, respectively. The marker is phage DNA with HindIII digestion and MegaBase II (GibcoBRL). (b) Schematic representation of tandem copies of packaged pHE700-B-GFP
The packaged pHE virions contain multimeric forms be able to transfer a genomic gene construct containing an intact promoter, introns and other cis-acting elements of the original monomeric vector after rolling-circle DNA replication (Figure 5b) . The transgene copy number to provide normal gene regulation by the cell. Our HSV amplicon vector may have utility for in vivo therefore depends on the insert size. The multiple copies of the transgene in the packaged vector provides severalgene therapy, particularly into the CNS due to neurotropism. 8, 18, 23, 24 For many neurodegenerative diseases where fold more transcription units than vectors derived from the entire HSV viral genome. Accordingly, transgene therapies do exist, such as Parkinson's disease, drugs which control symptoms often fail. This has led investiexpression was observed in tumor cells in as short a time as 5 h after pHE transduction of target cells (data not gators to evaluate genetic therapy to treat these diseases. Current approaches to neurologic diseases with genetic shown). The rapid, high-level transgene expression will provide an ideal system for studies of gene expression in therapies have been mostly restricted to ex vivo strategies with retroviral vectors; although, newly developed Lenti vitro or in vivo in situations where short-term, rapid onset gene expression is desired. Viral vector production pHE700-lac was transfected into E5 cells with Lipofectastrategies, allowing an immune response to the highly expressed transgene proteins.
mine per the manufacturer's protocol (GibcoBRL). Cells were trypsinized and plated at 6 × 10 5 cells/100 mm dish 2 days after transfection. Transfected cells were placed
Materials and methods
under selection with Hygromycin B (ICN Biomedical, Aurora, OH, USA) 1 day after plating. The selected hygConstruction of pHE vectors romycin-resistant E5 cells were super-infected with The pHE700 is a 10 617 bp plasmid generated from the helper virus (d120) when resistant colonies appeared, combination of components from several other plasmids.
generally after 2 weeks of drug selection. The colonies Plasmid pTO11 (the source for the 'a' packaging signal were trypsinized and 3 × 10 6 cells were plated on a 100 and the ori S of HSV-1, kindly provided by Dr N Stow, mm dish. When the cells were nearly confluent, 0.01 to MRC, Glasgow, UK) was restricted with NspI and ligated 0.1 MOI of d120 helper virus in 1 ml of Opti-MEM to generate PTO11-NspI. Plasmid p500 (kindly provided (GibcoBRL) was added. The viruses were allowed to by Dr Hayakawa, Kyushu University, Fukuoka, Japan) adsorb to the cells for 2 h at 37°C in a humidified, 5% was then restricted with XmnI and HindIII, and the frag-CO 2 incubator. The virus solutions were removed and 10 ment containing the EBNA-1 sequence was ligated to a ml of DMEM with 10% FBS was added and incubated XmnI and HindIII fragment of PTO11-NspI. The resulting for an additional 24 to 36 h. The medium containing cell plasmid p501 was restricted with XhoI and XmnI and ligdebris was collected and centrifuged and the vector ated to a XmnI and ClaI restricted fragment of p205 supernatants were used for virus titration and infection (kindly provided by Dr B Sugden, University of Wisconexperiments. sin, USA). The resultant plasmid p206 was restricted with NarI and HindIII and ligated to pTO11-NspI restricted Vector concentration with HindIII and BamHI. The resultant plasmid was Viral supernatant and cell debris were collected from termed pHE100. The pHE100 was then restricted with infected cell monolayers after complete cell lysis. The lysHindIII followed by ligation to a XbaI and NruI fragment ate was frozen and thawed three times at 37°C and then from pREP10 (Invitrogen, Carlsbad, CA, USA) containing centrifuged at 2400 g to pellet the cell debris. The superthe hygromycin resistance gene and the multi-cloning natant was filtered through a disposable Nalgene 0.8 m site (MCS) to create plasmid pHE600. The pHE600 was nylon filter bottle (Nalge, Rochester, NY, USA) to remove then restricted with SalI and the large fragment was isoany remaining cell debris. Thirty-four milliliters of viral lated and ligated to the SalI fragment of pCEP4 vector supernatant were added to a Beckman polyal-(Invitrogen) containing an expression cassette which has lomer Quick-Seal centrifuged tube (40 ml volume; a human cytomegalovirus (CMV) immediate-early gene Beckman, Palo Alto, CA, USA) on top of a 6 ml cushion enhancer-promoter and a simian virus 40 polyadenylof 25% sucrose in 1 × PBS. The tubes were then ultraation signal (SV40 poly A) to generate pHE700 vector.
centrifuged at 75 000 g at 4°C in a Beckman 55.2Ti rotor pHE700-lac was constructed by inserting a lacZ gene into for 16 h to pellet the virus particles. The pellet was resusHindIII and NotI sites of multiple cloning sites of pHE700. pended with 0.2-0.5 ml of sterile Hank's balanced salt The lacZ gene was from a HindIII-NotI fragment of solution (HBSS) buffer for further applications. pCDMV3-lac (kindly provided by Dr T Tsukada, Kyoto University, Japan). The 31.6 kb pHE700-B-GFP was conVector titration structed by ligation of a 16.8 kb BamHI fragment of
The viral stocks were serially diluted in Opti-MEM media phage DNA (GibcoBRL/Life Technologies, Gaithersburg, and placed on to confluent E5 cells monolayers in six-MD, USA) and a 4.2 kb NheI linearized phGFP-S65T plaswell plates. The viruses were allowed to adsorb to the mid (Clontech, Palo Alto, CA, USA) into the BamHI and cells for 2 h at 37°C. The virus solutions were aspirated NheI sites of the pHE700 vector. and the cells were washed with HBSS and overlaid with 2 ml DMEM containing 5% FBS and 0.3% methylcellulose and then incubated for an additional 3 days. Cells were Cells and viruses All cells were grown and maintained in DMEM fixed and plaques visualized by staining with 0.5% crystal violet for 10 min. The titers were reported as p.f.u./ml (GibcoBRL) containing 10% fetal bovine serum (FBS; GibcoBRL), glutamine and penicillin/streptomycin, and or b.f.u./ml. pHE700-lac viral stocks were titrated 24 h after infection of VA13 cells in 24-well plates. Cells were incubated at 37°C in a humidified, 5% CO 2 incubator. VA13 cells are SV40-transformed human WI38 fibroblast rinsed with HBSS and fixed for 5 min at room temperature in 2% formaldehyde, 0.3% glutaraldehyde in HBSS. cells (ATCC, Rockville, MD, USA). XP2OS xeroderma pigmentosum cells were kindly provided by Dr Takebe Following two additional rinses with HBSS, cells were stained with chromophore solution containing 0.1% X-gal (Kyoto University, Japan). T98G is a human glioblastoma cell line (ATCC 
